Swiss companies are at the front of the pack when it comes to investing in research and development (R&D) worldwide, according to a global business survey.
Accounting and consulting firm Ernst & Young (EY) found that Swiss companies spend 6.6% of their turnover on R&D, compared with an average of 3.8% worldwide.
The authors of the study, which was published on Thursday, analysed the investments of the 500 top-spending international companies in R&D. Expenditure in the sector increased by 6 percent in 2017 to 532 billion euros (CHF 601 billion), the report found, while two-thirds of the companies boosted research spending.
“Investment in research and development is increasing worldwide because rapid technological progress, ever shorter product cycles and rapidly changing consumer demands are driving companies to innovate,” explained Marcel Stalder, chief executive officer of EY Switzerland.
The Swiss companies in the selection earmarked the largest share of their turnover (6.6% in 2017) to research and development, ahead of competitors from the United States (5.9%), Sweden (4.4%), and Germany (4.1%).
The results show that Swiss companies have recognised early “the importance of innovation for their long-term international competitiveness and the need for high margins”, the study said.
Digital and pharma in the spotlight
In absolute terms, the top of the ranking is occupied by tech giants Amazons and Alphabet (Google’s parent company).
In Europe, the Volkswagen automotive group is the top spender, with an R&D budget of 11.6 billion euros in 2017.
Pharmaceutical companies are also well ranked, with Roche, Johnson & Johnson, and Merck & Co all making the top 10.
In all, eleven of the top 500 companies are Swiss, and their combined R&D investments came to some 23 billion euros in 2017.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
EU Commission president says Swiss-EU deal is ‘historic’ agreement
This content was published on
At a joint media conference with Swiss President Viola Amherd in Bern, European Commission President Ursula von der Leyen spoke of a "day of joy".
Switzerland and EU reach deal on future bilateral relations
This content was published on
Switzerland and the European Union have announced a political agreement to update their trading relationship after almost a decade of difficult talks.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss sign agreement to build China’s first zero-energy building
This content was published on
The project called “Swiss House Sunlon” is backed by Swiss companies and will be the first zero energy dwelling in China. The technology used in the building will come from the Swiss cleantech sector and is meant to serve as a showcase for Swiss innovation in the country. The agreement was signed on Thursday in…
The enigma explorations of Bruce Nauman at Schaulager
This content was published on
An ambitious retrospective of the elusive American artist runs alongside Art Basel and showcases works that trouble, amuse, shock and delight.
This content was published on
Each year, some half a million people die of malaria, many of them children. Switzerland is a world leader in research to combat the disease.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.